Skip to main content

Loading market ticker...

Natco Pharma

Healthcare NSE:NATCOPHARM

1027.55INR
25.65 ( 2.56%)

Last update at April 2, 2026, midnight

Day Range

978.451031.00
LowHigh

52 Week Range

725.14 1335.66
LowHigh

Fundamentals

  • Previous Close 1001.90
  • Market Cap 162936.26M
  • Volume1,054,328
  • P/E Ratio 10.59
  • EBITDA 16853.00M
  • Revenue TTM 43901.00M
  • Revenue Per Share TTM 245.10
  • Gross Profit TTM 36178.00M
  • Diluted EPS TTM 85.91

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 22914.00M 16735.00M 8619.00M 2022.00M 5796.00M
Net income 18854.00M 13883.00M 7153.00M 1700.00M 4409.00M
Total Revenue 44319.00M 40020.00M 27071.00M 19049.00M 16903.00M
Gross Profit 37045.00M 32533.00M 20798.00M 12234.00M 10824.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 86308.00M 69063.00M 56574.00M 51091.00M 47919.00M
Intangible assets 2087.00M 1371.00M 1326.00M 822.00M 94.00M
Other current assets 7514.00M 1852.00M 2290.00M 3043.00M 2583.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 496.00M 8163.00M 208.00M 853.00M 60.00M
Operating Cash 16968.00M 12523.00M 8491.00M 465.00M 2988.00M
Free Cash Flow 14280.00M 8936.00M 6435.00M -1962.00M 442.00M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NATCOPHARM
Natco Pharma 		25.65 2.56% 1027.55 162936.26 10.59
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-34.90 -2.02% 1693.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-50.00 -0.85% 5856.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-124.10 -3.02% 3987.20 1362716.66 63.48
CIPLA
Cipla Limited 		-3.50 -0.29% 1192.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.